Real-world experience with trastuzumab deruxtecan in patients with breast cancer: 6 month-interim analysis of an all-patient postmarketing surveillance in Japan

被引：0
|
作者：
Tsurutani, Junji
Mizutani, Hideki
Tanabe, Ayumi
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO3-17-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO3-17-07
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-world experience with trastuzumab deruxtecan among patients with gastric cancer: 4 month-interim analysis of an all-patient post-marketing surveillance study in Japan.
    Kawakami, Hisato
    Uchino, Kazuhiro
    Hashimoto, Wataru
    Muro, Kei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 273 - 273
  • [2] Real-world safety of trastuzumab deruxtecan with gastric cancer: All-patient post-marketing surveillance study in Japan.
    Kawakami, Hisato
    Uchino, Kazuhiro
    Hashimoto, Wataru
    Muro, Kei
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 399 - 399
  • [3] Pharmacodynamic analysis of eribulin safety in breast cancer patients using real-world postmarketing surveillance data
    Kawamura, Takahisa
    Kasai, Hidefumi
    Fermanelli, Valentina
    Takahashi, Toshiaki
    Sakata, Yukinori
    Matsuoka, Toshiyuki
    Ishii, Mika
    Tanigawara, Yusuke
    CANCER SCIENCE, 2018, 109 (09): : 2822 - 2829
  • [4] European real-world experience of patients with HER2+advanced/metastatic breast cancer accessing trastuzumab deruxtecan through a named patient program: first interim analysis of EUROPA T-DXd
    De laurentiis, Michelino
    Garcia-Saenz, Jose Angel
    Bianchini, Giampaolo
    Saura, Cristina
    Wildiers, Hans
    Allignol, Arthur
    Logue, Amanda
    Lucerna, Markus
    Stamenitis, Sabine
    CANCER RESEARCH, 2024, 84 (09)
  • [5] Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study
    Kaneko, Shuichi
    Ikeda, Kenji
    Matsuzaki, Yasushi
    Furuse, Junji
    Minami, Hironobu
    Okayama, Yutaka
    Sunaya, Toshiyuki
    Ito, Yuichiro
    Inuyama, Lyo
    Okita, Kiwamu
    JOURNAL OF GASTROENTEROLOGY, 2016, 51 (10) : 1011 - 1021
  • [6] Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study
    Shuichi Kaneko
    Kenji Ikeda
    Yasushi Matsuzaki
    Junji Furuse
    Hironobu Minami
    Yutaka Okayama
    Toshiyuki Sunaya
    Yuichiro Ito
    Lyo Inuyama
    Kiwamu Okita
    Journal of Gastroenterology, 2016, 51 : 1011 - 1021
  • [7] CNS efficacy of trastuzumab deruxtecan in metastatic breast cancer: A single-institution, real-world analysis.
    Zhang, Xiaojie
    Yeung, Kay T.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+Metastatic Breast Cancer: The DE-REAL Study
    Botticelli, Andrea
    Caputo, Roberta
    Scagnoli, Simone
    Pisegna, Simona
    De Laurentiis, Michelino
    Curigliano, Giuseppe
    Lambertini, Matteo
    Pantano, Francesco
    Palazzo, Antonella
    Paris, Ida
    Vernieri, Claudio
    Tedesco, Beatrice
    Giampaglia, Marianna
    Palleschi, Michela
    Ballatore, Zelmira
    Alesini, Daniele
    D'Auria, Giuliana
    Fabbri, Agnese
    Rossi, Luigi
    Verrazzo, Annarita
    Scafetta, Roberta
    Marinelli, Daniele
    Sposetti, Caterina
    Barberi, Vittoria
    Strigari, Lidia
    Marchetti, Paolo
    Santini, Daniele
    Fabi, Alessandra
    ONCOLOGIST, 2024, 29 (04): : 303 - 310
  • [9] Real-world data on the safety and efficacy of trastuzumab deruxtecan and sacituzumab govitecan in patients with advanced breast cancer: the experience of the Hellenic Cooperative Oncology Group
    Fountzilas, E.
    Lalla, T.
    Karakatsoulis, G.
    Papazisis, K.
    Exarchos, K.
    Koumarianou, A.
    Nikolaidi, A.
    Binas, I.
    Mauri, D.
    Karageorgopoulou, S.
    Razis, E.
    Christopoulou, A.
    Boutis, A.
    Douganiotis, G.
    Zagouri, F.
    Stamatopoulou, S.
    Spathas, N.
    Tryfonopoulos, D.
    Psyrri, A.
    Koutras, A.
    EUROPEAN JOURNAL OF CANCER, 2024, 200 : 2 - 2
  • [10] Real-world safety of nivolumab in patients with non-small-cell lung cancer in Japan: Postmarketing surveillance
    Yamamoto, Nobuyuki
    Nakanishi, Yoichi
    Gemma, Akihiko
    Nakagawa, Kazuhiko
    Sakamoto, Takahiko
    Akamatsu, Ayumi
    Ohe, Yuichiro
    CANCER SCIENCE, 2021, 112 (11) : 4692 - 4701
12345